Article Abstract

Icotinib improves progression free survival in epidermal growth factor receptor positive non-small cell lung cancer patients

Authors: Pranav Gupta, Anna Maria Barbuti, De-Shen Wang, Qingbin Cui, Zhe-Sheng Chen

Abstract

Lung cancer, as defined by the National Cancer Institute, is the uncontrolled proliferation of cells lining the air passages and tissues of the lungs (1). Lung cancer is the second most common cancer in both men and women (with prostate and breast as the most common in men and women, respectively).